Pharmaceutical Information Officer
Ensures scientific accuracy and legal compliance of all product information and advertising for medicinal products. Review of promotional material and handling of medical inquiries.
AMG § 74a · HWG
Talk to us about Pharmaceutical Information Officer
Three lines and you are in our inbox. We reply within one business day.
What is a pharmaceutical information officer?
A pharmaceutical information officer (Informationsbeauftragter) ensures that all information a pharmaceutical company communicates about its medicinal products is scientifically correct and legally permissible. The role guards the boundary between accurate, evidence-based product information and unlawful or misleading advertising, both towards healthcare professionals and, where permitted, the public.
The legal anchor is § 74a of the German Medicinal Products Act (Arzneimittelgesetz, AMG). It requires the marketing authorisation holder, who places medicinal products on the market, to appoint an information officer with the necessary expert knowledge. The information officer is responsible for ensuring that the information disseminated about a medicinal product corresponds to the latest scientific knowledge and to the approved summary of product characteristics (Fachinformation) and package leaflet.
Advertising itself is governed by the Heilmittelwerbegesetz (HWG, Gesetz über die Werbung auf dem Gebiete des Heilwesens). The HWG restricts advertising of medicinal products, distinguishes between professional and public advertising, lists mandatory particulars and prohibits misleading claims. The information officer reviews promotional material against both the AMG and the HWG before it is used.
The role is closely linked to, but distinct from, the qualified person responsible for pharmacovigilance and the responsible person for batch release. The information officer focuses on the correctness and lawfulness of communicated information rather than on manufacturing or safety surveillance. The required expert knowledge typically rests on a relevant scientific qualification, such as in pharmacy, medicine or a natural science, combined with knowledge of pharmaceutical advertising law. The officer also handles or oversees medical and scientific inquiries about the company's products.
Core duties of the pharmaceutical information officer
- Ensure all communicated product information matches the approved Fachinformation and package leaflet
- Review promotional and advertising material against the AMG and the Heilmittelwerbegesetz (HWG) before use
- Distinguish lawful professional advertising from prohibited or restricted public advertising
- Check that mandatory particulars and obligatory texts under the HWG are present and correct
- Reject or correct misleading, unbalanced or scientifically unsupported claims
- Handle and document medical and scientific inquiries about the company's medicinal products
- Keep product information aligned with the latest scientific knowledge and label changes
- Advise marketing, medical and sales teams on what may and may not be claimed
- Maintain records of reviewed and approved materials for the supervisory authority
- Cooperate with the qualified person for pharmacovigilance and regulatory affairs
When must a pharmaceutical information officer be appointed?
The duty to appoint an information officer falls on the holder of the marketing authorisation that places medicinal products on the German market, under § 74a AMG. The obligation arises as soon as a company markets authorised medicinal products, because every piece of product information and advertising disseminated for those products must be scientifically correct and legally compliant.
The information officer must have the necessary expert knowledge to assess scientific content and the legal limits of pharmaceutical advertising. In practice this means a relevant scientific background combined with sound knowledge of the AMG and the Heilmittelwerbegesetz. The marketing authorisation holder is responsible for selecting a suitable person and for enabling the officer to perform the review function effectively and free from undue commercial pressure.
The appointment is part of the company's regulatory set-up alongside other responsible persons required under the AMG. The competent supervisory authority of the federal state oversees compliance and can request evidence that an information officer is appointed and that materials are reviewed. Failure to appoint a qualified information officer or to ensure correct information can lead to regulatory measures and, where advertising breaches the HWG, to administrative or even criminal consequences. The officer's responsibility continues for as long as the company markets the products.
- Holding a marketing authorisation for medicinal products placed on the market
- Disseminating product information or advertising for medicinal products
- Launching a new medicinal product or a new indication
- Operating in professional or public pharmaceutical advertising
- Requirement under § 74a AMG for the marketing authorisation holder
- Supervisory authority requesting evidence of information review
Where pharmaceutical information officers are needed
- Pharmaceutical manufacturers and marketing authorisation holders
- Generic and biosimilar companies
- Over-the-counter and self-medication suppliers
- Vaccine and biologics producers
- Pharmaceutical distributors and licensors
- Contract sales and co-marketing organisations
- Consumer health and self-care brands
- Medical communications and agency partners
- Regulatory affairs service providers
- Companies importing and re-marketing medicinal products
How CIVAC supports the pharmaceutical information officer role
CIVAC gives the information officer a controlled review and record trail for product information and advertising. Each promotional item can be tracked as a task with a review status, an owner and the linked approved Fachinformation, so nothing reaches the field without sign-off under § 74a AMG and the HWG. The documentation pillar stores reviewed and released materials with their version history, ready for the supervisory authority to inspect. Medical and scientific inquiries can be logged and tracked to a documented answer. Recurring obligations, such as re-checking materials after a label change, become scheduled tasks. When the authority asks who approved which claim and on what scientific basis, the review history is exportable from one place rather than reconstructed from email threads.
Frequently asked questions about the pharmaceutical information officer
Need this officer role for your organisation?
Appoint our experts as your external officer or license CIVAC for your in-house team. Get in touch and we walk you through the right setup.